-

Deadline Approaching: Oracle Corporation (ORCL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith  

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming April 6, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Oracle Corporation (“Oracle” or the “Company”) (NYSE: ORCL) securities between June 12, 2025 and December 16, 2025, inclusive (the “Class Period”).

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ORACLE CORPORATION (ORCL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On September 25, 2025, analysts at Rothschild & Co. Redburn claimed that the market was “materially overestimate[ing]” future growth resulting from Oracle’s AI deals, warning that the Company’s promises of new revenues from its increased AI infrastructure business were “unlikely to materialize.”

On this news, Oracle’s stock price fell $17.13, or 5.6%, to close at $291.33 per share on September 25, 2025, thereby injuring investors.

Then, on December 10, 2025, Oracle released its second quarter fiscal 2026 financial results, missing consensus estimates in revenue growth, capital expenditures (“CapEx”), and negative free cash flow. The Company further revealed that it “now expect[ed] fiscal 2026 CapEx will be about $15 billion higher than [it] forecasted after Q1.”

On this news, Oracle’ stock price fell $24.16, or 10.8%, to close at $198.85 per share on December 11, 2025.

Further, on December 12, 2025, Bloomberg reported that Oracle had “pushed back the completion dates for some of the data centers it’s developing for the artificial intelligence model developer OpenAI to 2028 from 2027” due to “labor and material shortages.”

On this news, Oracle’s stock price fell $8.88, or 4.5%, to close at $189.97 per share on December 12, 2025.

Finally, on December 17, 2025, Financial Times reported that Oracle’s primary financial backer for its data center projects, Blue Owl Capital, had backed out of funding a $10 billion Oracle data center intended to serve OpenAI due to concerns about Oracle’s spending commitments and rising debt levels.

On this news, Oracle’s stock price fell $10.19, or 5.4%, to close at $178.46 per share on December 17, 2025, thereby injuring investors further.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Oracle's AI infrastructure strategy would result in massive increases in CapEx without equivalent, near-term growth in revenue; (2) the Company's substantially increased spending created serious risks involving Oracle's debt and credit rating, free cash flow, and ability to fund its projects, among other concerns; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Oracle securities during the Class Period, you may move the Court no later than April 6, 2026 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements.

Contact Us To Participate or Learn More:
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com,
Visit our website at: www.howardsmithlaw.com.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NYSE:ORCL

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INOVIO PHARMACEUTICALS, INC. (INO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your le...

Deadline Approaching: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith  

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 17, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Charming Medical Limited (“Charming” or the “Company”) (NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CHARMING MEDICAL LIMITED (MCTA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PA...

Law Offices of Howard G. Smith Encourages Kyndryl Holdings, Inc. (KD) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD) securities between August 7, 2024 and February 9, 2026, inclusive (the “Class Period”). Kyndryl investors have until April 13, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYNDRYL HOLDINGS, INC. (KD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH...
Back to Newsroom